Top Institutions in Ophthalmology - Retina Care
Institutions leading in this area are recognized for their pioneering clinical trials, regulatory science expertise, and translational research in retinal diseases and biologic therapies, including biosimilars. Their work encompasses rigorous analytical characterization, functional assays, and real-world evidence generation to support biosimilar adoption in retina care.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is internationally renowned for its leadership in retinal disease research and clinical trials, including pioneering work on anti-VEGF therapies and biosimilars. Their multidisciplinary approach integrates clinical care, translational research, and regulatory science.
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear has a strong track record in retinal disease research and early adoption of biosimilar therapies, supported by robust translational science and clinical trial infrastructure.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a leader in clinical research on retinal diseases and biologic therapies, with significant contributions to understanding biosimilar efficacy and safety in retina care.
-
#4
Moorfields Eye Hospital
London, England
Moorfields is a global leader in retinal disease management and health policy research, playing a key role in biosimilar adoption and access strategies in Europe and worldwide.
-
#5
Singapore National Eye Centre
Singapore, Singapore
The Singapore National Eye Centre is recognized for its clinical research in retinal diseases and biosimilars, with a focus on accessibility and cost-effectiveness in Asia-Pacific populations.